Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium
- PMID: 12948019
- DOI: 10.1023/a:1025001131513
Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium
Abstract
Purpose: The purpose of this work was to elucidate the asymmetric effect of P-gp on modulation of absorptive and secretory transport of compounds across polarized epithelium, to develop experimental parameters to quantify P-gp-mediated modulation of absorptive and secretory transport, and to elucidate how P-gp-mediated modulation of transport is affected by passive diffusion properties, interaction of the substrate with P-gp, and P-gp expression.
Methods: The permeability of a set of P-gp substrates was determined in absorptive and secretory directions in Madine-Darby Canine kidney (MDCK), Caco-2, and MDR-MDCK monolayers. The transport was also determined in the presence of GW918, a non-competitive P-gp inhibitor, to quantify the permeability without the influence of P-gp. From these two experimental permeability values in each direction, two new parameters, absorptive quotient (AQ) and the secretory quotient (SQ), were defined to express the functional activity of P-gp during absorptive and secretory transport, respectively. Western blot analysis was used to quantify P-gp expression in these monolayers and in normal human intestinal.
Results: P-gp expression in Caco-2 and MDR-MDCK monolayers was comparable to that in normal intestine, and much less in MDCK cells. For all models, the substrates encompassed a wide range of apparent permeability due to passive diffusion (PPD). The parameters AQ and SQ, calculated for all compounds, assessed the attenuation in absorptive and enhancement of secretory transport, respectively, normalized to the permeability due to passive diffusion. Analysis of these parameters showed that 1) P-gp affected absorptive and secretory transport differentially and 2) compounds could be stratified into distinct groups with respect to the modulation of their absorptive and secretory transport by P-gp. Compounds could be identified whose absorptive transport was either strongly affected or poorly affected by changes in P-gp expression. For certain compounds, AQ values showed parabolic relationship with respect to passive diffusivity, and for others AQ was unaffected by changes in passive diffusivity.
Conclusions: The relationship between attenuation of absorptive transport and enhancement of secretory transport of compounds by P-gp is asymmetric, and different for different sets of compounds. The relationship between attenuation of absorption by P-gp and passive diffusivity of compounds, their interaction potential with P-gp, and levels of P-gp expression is complex; however, compounds can be classified into sets based on these relationships. A classification system that describes the functional activity of P-gp with respect to modulation of absorptive and secretory transport was developed from these results.
Similar articles
-
Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.Pharm Res. 2003 Aug;20(8):1200-9. doi: 10.1023/a:1025049014674. Pharm Res. 2003. PMID: 12948018
-
Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.J Pharm Sci. 1999 Oct;88(10):1067-72. doi: 10.1021/js980378j. J Pharm Sci. 1999. PMID: 10514357
-
Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.Mol Pharm. 2005 Jan-Feb;2(1):12-21. doi: 10.1021/mp0499196. Mol Pharm. 2005. PMID: 15804173
-
Mechanistic analysis for drug permeation through intestinal membrane.Drug Metab Pharmacokinet. 2007 Apr;22(2):67-77. doi: 10.2133/dmpk.22.67. Drug Metab Pharmacokinet. 2007. PMID: 17495413 Review.
-
Drug exsorption from blood into the gastrointestinal tract.Pharm Res. 1998 Mar;15(3):371-6. doi: 10.1023/a:1011959828103. Pharm Res. 1998. PMID: 9563065 Review.
Cited by
-
The steady-state Michaelis-Menten analysis of P-glycoprotein mediated transport through a confluent cell monolayer cannot predict the correct Michaelis constant Km.Pharm Res. 2005 Oct;22(10):1667-77. doi: 10.1007/s11095-005-6627-z. Epub 2005 Sep 22. Pharm Res. 2005. PMID: 16180124
-
A novel screening strategy to identify ABCB1 substrates and inhibitors.Naunyn Schmiedebergs Arch Pharmacol. 2009 Jan;379(1):11-26. doi: 10.1007/s00210-008-0345-0. Epub 2008 Aug 29. Naunyn Schmiedebergs Arch Pharmacol. 2009. PMID: 18758752
-
Pharmacokinetic comparison to determine the mechanisms underlying the differential efficacies of cationic diamidines against first- and second-stage human African trypanosomiasis.Antimicrob Agents Chemother. 2014 Jul;58(7):4064-74. doi: 10.1128/AAC.02605-14. Epub 2014 May 5. Antimicrob Agents Chemother. 2014. PMID: 24798280 Free PMC article.
-
Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate.J Pharm Sci. 2017 Mar;106(3):906-919. doi: 10.1016/j.xphs.2016.12.003. Epub 2016 Dec 14. J Pharm Sci. 2017. PMID: 27986599 Free PMC article.
-
Abundance of Hepatic Transporters in Caucasians: A Meta-Analysis.Drug Metab Dispos. 2016 Oct;44(10):1550-61. doi: 10.1124/dmd.116.071183. Epub 2016 Aug 4. Drug Metab Dispos. 2016. PMID: 27493152 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous